313 related articles for article (PubMed ID: 22496645)
1. Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation.
Wu X; Robotham JM; Lee E; Dalton S; Kneteman NM; Gilbert DM; Tang H
PLoS Pathog; 2012; 8(4):e1002617. PubMed ID: 22496645
[TBL] [Abstract][Full Text] [Related]
2. A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host.
Sa-Ngiamsuntorn K; Wongkajornsilp A; Phanthong P; Borwornpinyo S; Kitiyanant N; Chantratita W; Hongeng S
Virol J; 2016 Apr; 13():59. PubMed ID: 27044429
[TBL] [Abstract][Full Text] [Related]
3. Hepatic cells derived from induced pluripotent stem cells of pigtail macaques support hepatitis C virus infection.
Sourisseau M; Goldman O; He W; Gori JL; Kiem HP; Gouon-Evans V; Evans MJ
Gastroenterology; 2013 Nov; 145(5):966-969.e7. PubMed ID: 23891978
[TBL] [Abstract][Full Text] [Related]
4. Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection.
Caron J; Pène V; Tolosa L; Villaret M; Luce E; Fourrier A; Heslan JM; Saheb S; Bruckert E; Gómez-Lechón MJ; Nguyen TH; Rosenberg AR; Weber A; Dubart-Kupperschmitt A
Stem Cell Res Ther; 2019 Jul; 10(1):221. PubMed ID: 31358055
[TBL] [Abstract][Full Text] [Related]
5. Cell death-inducing DFFA-like effector b is required for hepatitis C virus entry into hepatocytes.
Wu X; Lee EM; Hammack C; Robotham JM; Basu M; Lang J; Brinton MA; Tang H
J Virol; 2014 Aug; 88(15):8433-44. PubMed ID: 24829338
[TBL] [Abstract][Full Text] [Related]
6. Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions.
Xia Y; Carpentier A; Cheng X; Block PD; Zhao Y; Zhang Z; Protzer U; Liang TJ
J Hepatol; 2017 Mar; 66(3):494-503. PubMed ID: 27746336
[TBL] [Abstract][Full Text] [Related]
7. Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine model.
Carpentier A; Tesfaye A; Chu V; Nimgaonkar I; Zhang F; Lee SB; Thorgeirsson SS; Feinstone SM; Liang TJ
J Clin Invest; 2014 Nov; 124(11):4953-64. PubMed ID: 25295540
[TBL] [Abstract][Full Text] [Related]
8. Development of Hepatocyte-like Cell Derived from Human Induced Pluripotent Stem cell as a Host for Clinically Isolated Hepatitis C Virus.
Sa-Ngiamsuntorn K; Hongeng S; Wongkajornsilp A
Curr Protoc Stem Cell Biol; 2017 Aug; 42(1):4A.13.1-4A.13.34. PubMed ID: 28806853
[TBL] [Abstract][Full Text] [Related]
9. Human embryonic stem cell-derived hepatoblasts are an optimal lineage stage for hepatitis C virus infection.
Yan F; Wang Y; Zhang W; Chang M; He Z; Xu J; Shang C; Chen T; Liu J; Wang X; Pei X; Wang Y
Hepatology; 2017 Sep; 66(3):717-735. PubMed ID: 28236326
[TBL] [Abstract][Full Text] [Related]
10. Induced pluripotent stem cells (iPSCs) in the modeling of hepatitis C virus infection.
Cheng L; Zhang Y; Nan Y; Qiao L
Curr Stem Cell Res Ther; 2015; 10(3):216-9. PubMed ID: 25248675
[TBL] [Abstract][Full Text] [Related]
11. Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
Raymond VA; Selliah S; Ethier C; Houle R; Jouan L; Maniere T; Lamarre D; Willems B; Bilodeau M
Liver Int; 2009 Jul; 29(6):942-9. PubMed ID: 19302183
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-27a modulates HCV infection in differentiated hepatocyte-like cells from adipose tissue-derived mesenchymal stem cells.
Choi JE; Hur W; Kim JH; Li TZ; Lee EB; Lee SW; Kang W; Shin EC; Wakita T; Yoon SK
PLoS One; 2014; 9(5):e91958. PubMed ID: 24824429
[TBL] [Abstract][Full Text] [Related]
13. N-Myc Downstream-Regulated Gene 1 Restricts Hepatitis C Virus Propagation by Regulating Lipid Droplet Biogenesis and Viral Assembly.
Schweitzer CJ; Zhang F; Boyer A; Valdez K; Cam M; Liang TJ
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118118
[TBL] [Abstract][Full Text] [Related]
14. Use of human hepatocytes to investigate HCV infection.
Pichard-Garcia L; Briolotti P; Larrey D; Sa-Cunha A; Suc B; Laporte S; Maurel P
Methods Mol Biol; 2010; 640():447-62. PubMed ID: 20645067
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C Virus Infection of Cultured Cells and Primary Human Hepatocytes.
Lowey B; Li Q
Curr Protoc Cell Biol; 2018 Sep; 80(1):e54. PubMed ID: 30058773
[TBL] [Abstract][Full Text] [Related]
16. Unraveling the dynamics of hepatitis C virus adaptive mutations and their impact on antiviral responses in primary human hepatocytes.
Frericks N; Brown RJP; Reinecke BM; Herrmann M; Brüggemann Y; Todt D; Miskey C; Vondran FWR; Steinmann E; Pietschmann T; Sheldon J
J Virol; 2024 Mar; 98(3):e0192123. PubMed ID: 38319104
[TBL] [Abstract][Full Text] [Related]
17. Functional innate immunity restricts Hepatitis C Virus infection in induced pluripotent stem cell-derived hepatocytes.
Schöbel A; Rösch K; Herker E
Sci Rep; 2018 Mar; 8(1):3893. PubMed ID: 29497123
[TBL] [Abstract][Full Text] [Related]
18. Primary hepatocyte culture supports hepatitis C virus replication: a model for infection-associated hepatocarcinogenesis.
Banaudha K; Orenstein JM; Korolnek T; St Laurent GC; Wakita T; Kumar A
Hepatology; 2010 Jun; 51(6):1922-32. PubMed ID: 20512986
[TBL] [Abstract][Full Text] [Related]
19. Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus.
Roelandt P; Obeid S; Paeshuyse J; Vanhove J; Van Lommel A; Nahmias Y; Nevens F; Neyts J; Verfaillie CM
J Hepatol; 2012 Aug; 57(2):246-51. PubMed ID: 22521345
[TBL] [Abstract][Full Text] [Related]
20. Development of mouse hepatocyte lines permissive for hepatitis C virus (HCV).
Aly HH; Oshiumi H; Shime H; Matsumoto M; Wakita T; Shimotohno K; Seya T
PLoS One; 2011; 6(6):e21284. PubMed ID: 21731692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
